Daewoong Co., Ltd. (003090.KS)
KRW 20450.0
(0.74%)
KRW 20450.0
(0.74%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 152.66 Billion KRW | 48.85% |
| 2022 | 102.56 Billion KRW | 30.27% |
| 2021 | 78.73 Billion KRW | -19.97% |
| 2020 | 98.37 Billion KRW | 57.56% |
| 2019 | 62.43 Billion KRW | 109.08% |
| 2018 | 29.86 Billion KRW | -54.92% |
| 2017 | 66.25 Billion KRW | 234.07% |
| 2016 | 19.83 Billion KRW | -48.66% |
| 2015 | 38.62 Billion KRW | 62.21% |
| 2014 | 23.81 Billion KRW | -41.6% |
| 2013 | 40.77 Billion KRW | -7.76% |
| 2012 | 44.19 Billion KRW | 2.15% |
| 2011 | 43.26 Billion KRW | 33.7% |
| 2010 | 32.36 Billion KRW | 61.72% |
| 2009 | 20.01 Billion KRW | 26.03% |
| 2008 | 15.87 Billion KRW | -46.41% |
| 2007 | 29.62 Billion KRW | 22.01% |
| 2006 | 24.28 Billion KRW | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 19.97 Billion KRW | -5.33% |
| 2024 Q1 | 21.1 Billion KRW | -44.17% |
| 2023 Q2 | 37.12 Billion KRW | -3.4% |
| 2023 Q4 | 37.8 Billion KRW | -3.82% |
| 2023 FY | 152.66 Billion KRW | 48.85% |
| 2023 Q3 | 39.3 Billion KRW | 5.88% |
| 2023 Q1 | 38.42 Billion KRW | 3349.78% |
| 2022 Q2 | 32.02 Billion KRW | 36.57% |
| 2022 FY | 102.56 Billion KRW | 30.27% |
| 2022 Q4 | 1.11 Billion KRW | -97.14% |
| 2022 Q3 | 38.9 Billion KRW | 21.49% |
| 2022 Q1 | 23.44 Billion KRW | -22.92% |
| 2021 Q3 | 26.82 Billion KRW | 45.84% |
| 2021 FY | 78.73 Billion KRW | -19.97% |
| 2021 Q1 | 3.16 Billion KRW | -94.48% |
| 2021 Q2 | 18.39 Billion KRW | 482.1% |
| 2021 Q4 | 30.42 Billion KRW | 13.39% |
| 2020 FY | 98.37 Billion KRW | 57.56% |
| 2020 Q4 | 57.2 Billion KRW | 274.88% |
| 2020 Q1 | 15.51 Billion KRW | 66.69% |
| 2020 Q2 | 10.4 Billion KRW | -32.95% |
| 2020 Q3 | 15.26 Billion KRW | 46.73% |
| 2019 FY | 62.43 Billion KRW | 109.08% |
| 2019 Q4 | 9.3 Billion KRW | -17.64% |
| 2019 Q1 | 11.94 Billion KRW | 205.14% |
| 2019 Q3 | 11.29 Billion KRW | -62.2% |
| 2019 Q2 | 29.88 Billion KRW | 150.19% |
| 2018 FY | 29.86 Billion KRW | -54.92% |
| 2018 Q1 | 14.45 Billion KRW | -46.73% |
| 2018 Q2 | 12.71 Billion KRW | -12.05% |
| 2018 Q4 | -11.36 Billion KRW | -180.83% |
| 2018 Q3 | 14.05 Billion KRW | 10.56% |
| 2017 Q4 | 27.13 Billion KRW | 92.4% |
| 2017 Q2 | 12.23 Billion KRW | -4.25% |
| 2017 FY | 66.25 Billion KRW | 234.07% |
| 2017 Q3 | 14.1 Billion KRW | 15.26% |
| 2017 Q1 | 12.77 Billion KRW | -11.32% |
| 2016 FY | 19.83 Billion KRW | -48.66% |
| 2016 Q2 | -2.76 Billion KRW | -75.08% |
| 2016 Q4 | 14.4 Billion KRW | 47.59% |
| 2016 Q1 | -1.57 Billion KRW | -129.97% |
| 2016 Q3 | 9.76 Billion KRW | 453.3% |
| 2015 Q4 | 5.26 Billion KRW | -48.11% |
| 2015 Q2 | 11.94 Billion KRW | 6.09% |
| 2015 FY | 38.62 Billion KRW | 62.21% |
| 2015 Q1 | 11.26 Billion KRW | 454.93% |
| 2015 Q3 | 10.14 Billion KRW | -15.05% |
| 2014 Q4 | 2.02 Billion KRW | 43.89% |
| 2014 FY | 23.81 Billion KRW | -41.6% |
| 2014 Q3 | 1.41 Billion KRW | -85.58% |
| 2014 Q2 | 9.77 Billion KRW | -7.67% |
| 2014 Q1 | 10.59 Billion KRW | 181.85% |
| 2013 FY | 40.77 Billion KRW | -7.76% |
| 2013 Q2 | 14.19 Billion KRW | 39.51% |
| 2013 Q3 | 12.63 Billion KRW | -11.01% |
| 2013 Q4 | 3.75 Billion KRW | -70.26% |
| 2013 Q1 | 10.17 Billion KRW | 78.77% |
| 2012 Q1 | 14.79 Billion KRW | 0.0% |
| 2012 FY | 44.19 Billion KRW | 2.15% |
| 2012 Q4 | 5.69 Billion KRW | -18.88% |
| 2012 Q3 | 7.01 Billion KRW | -43.93% |
| 2012 Q2 | 12.51 Billion KRW | -15.41% |
| 2011 Q1 | 4.13 Billion KRW | 0.0% |
| 2011 FY | 43.26 Billion KRW | 33.7% |
| 2011 Q4 | - KRW | -100.0% |
| 2011 Q3 | 2.22 Billion KRW | 30.57% |
| 2011 Q2 | 1.7 Billion KRW | -58.86% |
| 2010 Q1 | - KRW | -100.0% |
| 2010 FY | 32.36 Billion KRW | 61.72% |
| 2010 Q2 | 2.22 Billion KRW | 0.0% |
| 2010 Q3 | 9.4 Billion KRW | 323.14% |
| 2009 Q3 | 1.63 Billion KRW | -86.25% |
| 2009 FY | 20.01 Billion KRW | 26.03% |
| 2009 Q1 | - KRW | -100.0% |
| 2009 Q2 | 11.89 Billion KRW | 0.0% |
| 2009 Q4 | 12 Billion KRW | 633.42% |
| 2008 Q4 | 5.2 Billion KRW | 166.93% |
| 2008 Q1 | - KRW | -100.0% |
| 2008 Q3 | 1.94 Billion KRW | -72.93% |
| 2008 Q2 | 7.2 Billion KRW | 0.0% |
| 2008 FY | 15.87 Billion KRW | -46.41% |
| 2007 Q2 | 6.57 Billion KRW | 0.0% |
| 2007 Q4 | 7.46 Billion KRW | 9.78% |
| 2007 FY | 29.62 Billion KRW | 22.01% |
| 2007 Q3 | 6.79 Billion KRW | 3.36% |
| 2006 FY | 24.28 Billion KRW | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| PharmGen Science, Inc. | 5.72 Billion KRW | -2565.597% |
| Wooridul Huebrain Limited | -14.54 Billion KRW | 1149.948% |